KATHMANDU, Nov 28: While the government has stepped up its efforts to conduct another investment summit, experts and private sector stakeholders have criticized the government for failing to implement necessary provisions that were committed in the previous editions to attract the foreign direct investment (FDI).
The Make in Nepal initiative, jointly started by the government and the private sector, had envisioned four targets to boost the job market and the economy, but they all failed.
Once the bill is endorsed by the lower house, the Commission for the Investigation of Abuse of Authority will be able to investigate private firms linked to public interest.
news
Phase-III trial of favipiravir starts in Kathmandu and Pokhara Kathmandu Post
Kathmandu, Dec. 10 Nepal Health Research Council has decided to test antiviral medicine favipiravir on Covid-19 patients admitted to hospitals in Kathmandu and Pokhara.
The drug, which is being administered under a phase-III trial, will be given to 600 patients with mild or moderate symptoms of the contagious disease. Yes the trial has started in Kathmandu and in Pokhara, a doctor involved in the study, told the post, asking not to be named,
Favipiravir, originally made to treat flu in Japan, is being manufactured by Deurali-Janta Pharmaceuticals Pvt. Ltd in Nepal.